Question 1

Does Ubs own NVCT stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Ubs holds 69,200 shares of NVCT (Nuvectis Pharma), worth $1.3M.

Question 2

How many shares of NVCT does Ubs own?

Accepted Answer

As of its Q2 2026 13F, Ubs holds 69,200 shares of NVCT (Nuvectis Pharma).

Question 3

What is Ubs' NVCT position worth?

Accepted Answer

As of its Q2 2026 13F, Ubs' NVCT position is worth $1.3M.

Question 4

Is Ubs buying or selling NVCT?

Accepted Answer

In Q2 2026, Ubs increased its NVCT position by 30,637 shares (+79.5%).

Question 5

When did Ubs first buy NVCT?

Accepted Answer

Ubs first reported NVCT in its Q1 2022 13F and has listed it in 16 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	69,200	+79.5%	$1.3M	0.0%	$18.39	39
2026-Q1	Increased	38,563	+360.4%	$298,092	0.0%	$7.73	26
2025-Q4	Decreased	8,375	-67.1%	$63,231	0.0%	$7.55	0
2025-Q3	Increased	25,469	+148.3%	$153,323	0.0%	$6.02	25
2025-Q2	Decreased	10,258	-90.8%	$76,627	0.0%	$7.47	0
2025-Q1	Increased	111,520	+4078.3%	$1.1M	0.0%	$9.77	41
2024-Q4	Increased	2,669	+242x	$14,440	0.0%	$5.41	20
2024-Q3	Decreased	11	-15.4%	$69	0.0%	$6.29	0

NVCTShowing 8 of 17 quarters

NVCT
Showing 8 of 17 quarters